Live Analyst Rating Changes 24957 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Lance Wilkes
BERN

Lance Wilkes

Bernstein
Wall Street Analyst
★★★☆☆
#1294
on 13Foresight · ranked by our own returns
49%
Success Rate
+4.2%
Average Return
21 of 43 calls profitable · +2.9% vs benchmark
S&P 500 (SPY)
🔒 3-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 49% of Lance Wilkes's ratings turned a profit when each position was held for 1 year — averaging +4.2% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

101 Buy 57 Hold 0 Sell
Lance's Stock Coverage 9 ratings · 2026-08-16
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
CNC
Centene
 Aug 14, 2026 BUY Buy
+6.5% avg upside
29 analysts
$79.00
17.14% Upside
 +0.0% ·
CI
Cigna
 Aug 14, 2026 BUY Strong Buy
+22.8% avg upside
29 analysts
$381.00
34.86% Upside
 +0.0% ·
CVS
CVS Health
 Aug 14, 2026 BUY Strong Buy
+9.0% avg upside
39 analysts
$106.00
9.18% Upside
 +0.0% ·
HCA
HCA Healthcare
 Aug 14, 2026 HOLD Buy
+0.8% avg upside
36 analysts
$426.00
5.22% Upside
 +0.0% ·
HUM
Humana
 Aug 14, 2026 BUY Buy
+8.2% avg upside
34 analysts
$425.00
9.15% Upside
 · ·
MOH
Molina Healthcare
 Aug 14, 2026 BUY Hold
+11.2% avg upside
26 analysts
$266.00
25.21% Upside
 +0.0% ·
UNH
UnitedHealth
 Aug 14, 2026 BUY Strong Buy
+13.4% avg upside
36 analysts
$512.00
27.48% Upside
 · ·
ELV
Elevance Health
 Aug 14, 2026 BUY Strong Buy
+12.7% avg upside
33 analysts
$488.00
22.00% Upside
 +0.0% ·
AGL
Agilon Health
 Aug 14, 2026 HOLD Buy
-31.1% avg upside
26 analysts
$86.00
11.31% Downside
 +0.0% ·
🔒 4 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Lance Wilkes — Frequently Asked Questions
How accurate are Lance Wilkes's stock ratings?
Based on the calls 13Foresight could measure, about 49% of Lance's ratings were profitable over a one-year hold, with an average return of +4.2% per rating, or +2.9% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Lance ranked on 13Foresight?
Lance Wilkes is currently ranked #1294 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Lance cover?
Lance most recently has ratings on CNC, CI, CVS, HCA, HUM, MOH, UNH, ELV, AGL. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.